Initial Experience with Renal Denervation for the Treatment of Resistant Hypertension - The Utility of Novel Anesthetics and Metaiodobenzylguanidine Scintigraphy (MIBG)

BACKGROUND: The Symplicity-HTN 3 trial failed to show significant difference in blood pressure (BP) lowering between patients undergoing catheter-based renal denervation (RDN) and the sham-procedure arm of the study. However, there is still optimism about the role of RDN in the treatment of resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziakas, Antonios, Petroglou, Dimitrios, Moralidis, Efstratios, Tsioufis, Konstantinos, Doumas, Mihalis, Argiriadou, Elena, Savopoulos, Christos, Hadjimiltiades, Stavros, Stiliadis, Ioannis, Kouparanis, Antonios, Katranas, Sotirios, Lillis, Leonidas, Koutsakis, Athanasios, Karvounis, Haralambos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974823/
https://www.ncbi.nlm.nih.gov/pubmed/27583041
http://dx.doi.org/10.2174/1874192401610010163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974823/
https://www.ncbi.nlm.nih.gov/pubmed/27583041
http://dx.doi.org/10.2174/1874192401610010163

Ejemplares similares